NewLimit, which plans to take its young-again cell reprogramming therapy into the clinic next year, raised a $435 million ...

A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...

T, has transformed treatment for blood cancers. The immunotherapy involves reprogramming a patient's own immune cells to ...

Company has now raised $6 million since founding to advance mRNA-based therapeutics designed to turn tumor cells into immune-activating cells ...

Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...

A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...

NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...

A team has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their ...

On Dec. 2, 2020, the international journal Nature splashed the cover with a retinal image and the bold headline "Turning back time." A title more fitting for a movie or novel referred to a research ...

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the ...